Tongji Hospital of Tongji Medical College of Huazhong University of Science and Technology, Wuhan 430030, Hubei, China.
Inflamm Res. 2012 Oct;61(10):1155-65. doi: 10.1007/s00011-012-0510-2. Epub 2012 Jun 23.
We investigated a possible imbalance between T helper (Th)17 and CD4+ CD25+ forkhead/winged helix transcription factor (Foxp3) T regulatory (Treg) cells in patients with carotid artery plaques.
From November 2009 to September 2010, we enrolled 126 males and 104 females with mean age 68.24 ± 6.71 years.
Based on carotid artery sonography, the 230 subjects were categorized into three groups: plaque negative; stable plaques; and unstable plaques.
Th17 and Treg cell frequencies, relevant plasma cytokines (IL-17, IL-6, IL-23, and TNF-α), and RORγt mRNA levels were determined.
Compared to plaque negative, Th17 cells, Th17-related cytokines (IL-17, IL-6, IL-23, and TNF-α), and RORγt mRNA levels were higher with stable plaques, and highest with unstable plaques. The opposite trend was found for Treg cells, Treg-related cytokines (IL-10 and TGF-β1), and Foxp3 mRNA. Th17 cell frequencies were significantly negatively correlated with Treg cell frequencies.
Our investigation demonstrated that there is a Th17/Treg functional imbalance in patients with unstable carotid atherosclerotic plaques. Th17 cells may promote atherogenesis, while Treg cells may have a protective role against atherosclerosis plaques. An imbalance of Th17/Treg cells may offer a new direction for the treatment of atherosclerosis.
我们研究了颈动脉斑块患者中辅助性 T 细胞(Th)17 与 CD4+ CD25+叉头/翅膀状螺旋转录因子(Foxp3)调节性 T(Treg)细胞之间可能存在的失衡。
2009 年 11 月至 2010 年 9 月,我们纳入了 126 名男性和 104 名女性患者,平均年龄为 68.24±6.71 岁。
根据颈动脉超声检查,将 230 例患者分为三组:斑块阴性组、稳定斑块组和不稳定斑块组。
测定 Th17 和 Treg 细胞频率、相关血浆细胞因子(IL-17、IL-6、IL-23 和 TNF-α)和 RORγt mRNA 水平。
与斑块阴性组相比,稳定斑块组 Th17 细胞、Th17 相关细胞因子(IL-17、IL-6、IL-23 和 TNF-α)和 RORγt mRNA 水平较高,不稳定斑块组最高。Treg 细胞、Treg 相关细胞因子(IL-10 和 TGF-β1)和 Foxp3 mRNA 则呈现相反的趋势。Th17 细胞频率与 Treg 细胞频率呈显著负相关。
我们的研究表明,不稳定颈动脉粥样硬化斑块患者存在 Th17/Treg 功能失衡。Th17 细胞可能促进动脉粥样硬化形成,而 Treg 细胞可能对动脉粥样硬化斑块具有保护作用。Th17/Treg 细胞失衡可能为动脉粥样硬化的治疗提供新方向。